Thrombospondin-1-mediated macrophage efferocytosis dysfunction exacerbates intestinal pathology in Hirschsprung's disease
Authors:
Open Access
- 11 February 2026
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 174, 116344
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82270713)
This publication has 42 references indexed in Scilit:
- Exosomes derived from M1-macrophage promote enteric neuronal injury via MMP8-TGF-β pathwayJournal of Advanced Research, 2025
- Nonylphenol exposure increases the risk of Hirschsprung’s disease by inducing macrophage M1 polarizationEcotoxicology and Environmental Safety, 2025
- Insulin-stimulated translocation of the fatty acid transporter CD36 to the plasma membrane is mediated by the small GTPase Rac1 in adipocytesCellular Signalling, 2024
- Hirschsprung disease: a cost analysis study of the direct, indirect costs and financial coping strategies for the surgical management in Western UgandaPediatric Surgery International, 2024
- Macrophage phenotypes and functions: resolving inflammation and restoring homeostasisTrends in Immunology, 2023
- Intestinal fibrosis in aganglionic segment of Hirschsprung's disease revealed by single‐cell RNA sequencingClinical and Translational Medicine, 2023
- Efferocytosis induces macrophage proliferation to help resolve tissue injuryCell Metabolism, 2021
- Literature review: enteric nervous system development, genetic and epigenetic regulation in the etiology of Hirschsprung's diseaseHeliyon, 2021
- SrGAP2-Dependent Integration of Membrane Geometry and Slit-Robo-Repulsive Cues Regulates Fibroblast Contact Inhibition of LocomotionDevelopmental Cell, 2015
- Probiotic prophylaxis after pullthrough for Hirschsprung disease to reduce incidence of enterocolitis: A prospective, randomized, double-blind, placebo-controlled, multicenter trialJournal of Pediatric Surgery, 2013